Supriya Lifesci.

50
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE07RO01027
  • NSEID: SUPRIYA
  • BSEID: 543434
INR
957.70
51.4 (5.67%)
BSENSE

Sep 21, 03:30 PM

BSE+NSE Vol: 5.63 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 18.86% vs 22.12% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 12.75% vs 50.77% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 12.04% vs -20.09% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 11.26% vs 57.80% in Mar 2025

Compare Profit and Loss Results of Supriya Lifesci.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
914.00
729.00
185.00
25.38%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
86.00
0.00
86.00
0%
Net Sales
827.00
729.00
98.00
13.44%
Expenditure (Ex Depriciation)
Stock Adjustments
-11.00
-25.00
14.00
56.00%
Raw Materials Consumed
265.00
368.00
-103.00
-27.99%
Power & Fuel Cost
29.00
12.00
17.00
141.67%
Employee Cost
96.00
121.00
-25.00
-20.66%
Operating Expenses
80.00
20.00
60.00
300.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
32.00
58.00
-26.00
-44.83%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
14.00
19.00
-5.00
-26.32%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
533.00
595.00
-62.00
-10.42%
Operating Profit (PBDIT) excl Other Income
294.00
134.00
160.00
119.40%
Other Income
11.00
43.00
-32.00
-74.42%
Operating Profit (PBDIT)
305.00
177.00
128.00
72.32%
Interest
1.00
11.00
-10.00
-90.91%
Profit before Depriciation and Tax
303.00
166.00
137.00
82.53%
Depreciation
28.00
31.00
-3.00
-9.68%
Profit Before Taxation & Exceptional Items
275.00
135.00
140.00
103.70%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
274.00
133.00
141.00
106.02%
Provision for Tax
65.00
36.00
29.00
80.56%
Profit After Tax
209.00
96.00
113.00
117.71%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
781.00
956.00
-175.00
-18.31%
Profit Available for appropriations
991.00
1,053.00
-62.00
-5.89%
Appropriations
991.00
1,053.00
-62.00
-5.89%
Equity Dividend (%)
50%
100%
-50.00
Earnings Per Share
25.98
9.17
16.81
183.32%
Profit And Loss - Net Sales
Net Sales 827.88 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 18.86% vs 22.12% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 294.05 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 12.75% vs 50.77% in Mar 2025

Profit And Loss - Interest
Interest 1.89 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 12.04% vs -20.09% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 209.12 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 11.26% vs 57.80% in Mar 2025